Abstract:Introduction: The influence of preoperative hemoglobin levels on outcomes of patients undergoing esophagectomy for cancer is not clearly defined. The goal of this article was to explore the association between combined modality therapy, preoperative anemia status, and perioperative blood transfusion and risk of postoperative complications among patients undergoing esophageal resection. Methods: From a retrospective esophageal database, 413 patients were identified. Anemia was defined according to the World Health Organization classification of <13 g/dL or <12 g/dL for men or women, respectively. Statistical analysis was performed with analysis of variance, Pearson's chi(2), or Fisher exact test as appropriate. The independent association of anemia, blood transfusion, and combined modality treatment on risk of postoperative complications were examined using multiple logistic regression. Results: Information on combined modality treatment, preoperative hemoglobin levels, and blood transfusion was available for 413 patients, of whom 57% received combined modality treatment. Overall 197 (47.6%) patients were preoperatively found to be anemic, and those who had received combined modality treatment were more likely to be anemic (60.6% versus 30.7%, P < 0.001). Anemic patients required more blood transfusions than nonanemic patients (46.7% versus 29.6%, P < 0.001). Seventy-five percent of patients who required transfusion during the hospital stay had received combined modality treatment (P = 0.01). Combined modality treatment and anemia were not associated with increased risk of complications. Patients with any perioperative complication and surgical site infections were more likely to have received blood transfusion compared to patients without complications (OR = 1.73; 95% CI 1.04-2.87 and OR = 2.98; 95% CI 1.04-8.55; respectively). Conclusions: Overall, we determined that administration of neoadjuvant treatment to esophageal cancer patients was not associated with an increased rate of perioperative complications. Preoperative anemia did not predict worsened short-term outcomes, but increased the chances of red blood cell transfusion, which were significantly associated with higher overall complications and increased risk of surgical site infections. These data confirm previous studies that allogenic red blood cell transfusions are independent risk factors for increased morbidity and mortality and should be minimized during surgery for esophageal cancer.

The Effect of Blood Transfusion During Esophagectomy on Immune Function for Patient with Esophageal Carcinoma

Effects of Perioperative Sequential Treatment on Recovery of Patients with Esophageal or Cardiac Carcinoma

Effect of Perioperative Autologous Versus Allogeneic Blood Transfusion on the Immune System in Gastric Cancer Patients

Impact of pulmonary infection after radical esophagectomy on serum inflammatory markers, pulmonary function indices, and prognosis

Effects of blood transfusion on cellular immuno-function in patients with laryngeal carcinoma

Clinical implication of the changes in peripheral blood lymphocyte subsets and TNF and related factors in patients with esophageal carcinoma

Effect of Allogeneic Blood Transfusion and Preoperative Autologous Blood Donation on Perioperative Immune Function in Patients with Gastrointestinal Tumor

Perioperative blood transfusions and decreased long-term survival in esophageal cancer

Effects of blood transfusion on the immune responsiveness and survival of cancer patients: a prospective study

Effect of neoadjuvant therapy on serum transforming growth factor-β, squamous cell carcinoma associated antigen, and prognosis in patients with locally advanced esophageal cancer

Effect of neoadjuvant therapy on serum transforming growth factor-, squamous cell carcinoma associated antigen, and prognosis in patients with locally advanced esophageal cancer

Correlations between neoadjuvant treatment, anemia, and perioperative complications in patients undergoing esophagectomy for cancer

Effects of different anesthesia methods on perioperative immune function and long-term regression of patients undergoing thoracoscopic radical esophagectomy for esophageal cancer

Immunologic Changes to Autologous Transfusion after Operational Trauma in Malignant Tumor Patients: Neopterin and Interleukin-2

Effects of Different Anesthetic and Analgesic Methods on Cellular Immune Function and Stress Hormone Levels in Patients Undergoing Esophageal Cancer Surgery

[Effects of minimally invasive versus open esophagectomy on circulating tumor cells in patients with esophageal cancer]

The Effect of Predeposited Autologous Blood Transfusion Combined with Allogeneic NK Cell Infusion on the Immune Function of Postoperative Patients With Gastric Cancer

Effect of Perioperative Blood Transfusion on Prognosis of Patients with Gastric Cancer: a Retrospective Analysis of a Single Center Database

Clinical study of different nutrition support for patients with perioperative esophageal cancer

Association between fibrosis around the tumor and postoperative infectious complication in patients with esophageal cancer who underwent preoperative therapy

Efficacy of immunonutritional supplement after neoadjuvant chemotherapy in patients with esophageal cancer